Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie.

作者: P. Mariani , S. Piperno-Neumann , V. Servois , M.G. Berry , T. Dorval

DOI: 10.1016/J.EJSO.2009.02.016

关键词:

摘要: Abstract Background Uveal melanoma is characterised by a high prevalence of liver metastases and poor prognosis. Aim To review the evolving surgical management this challenging condition at single institution over 16-year period. Patients Methods Between January 1991 June 2007, among 3873 patients with uveal melanoma, 798 had metastases. We undertook detailed retrospective their clinical records procedures. The data was evaluated both uni- multivariate statistical analysis for predictive survival indicators. Results 255 underwent resection. median interval between ocular tumour diagnosis surgery 68 months (range 19–81). Liver either microscopically complete (R0; n  = 76), incomplete (R1;  = 22) or macroscopically (R2;  = 157). overall postoperative 14 months, but increased to 27 when R0 resection possible. With analysis, four variables were found independently correlate prolonged survival: an from primary >24 comprehensiveness (R0), number resected (≤4) absence miliary disease. Conclusions Surgical resection, possible, able almost double appears present optimal way improving prognosis in metastatic melanoma. Advances medical treatments will be required further improve survival.

参考文章(15)
S Leyvraz, V Spataro, J Bauer, S Pampallona, R Salmon, T Dorval, R Meuli, M Gillet, F Lejeune, L Zografos, Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. Journal of Clinical Oncology. ,vol. 15, pp. 2589- 2595 ,(1997) , 10.1200/JCO.1997.15.7.2589
N Bornfeld, G Prescher, R Becher, H Hirche, K-H Jöckel, B Horsthemke, Prognostic implications of monosomy 3 in uveal melanoma The Lancet. ,vol. 347, pp. 1222- 1225 ,(1996) , 10.1016/S0140-6736(96)90736-9
S. Rajpal, R. Moore, C. P. Karakousis, Survival in metastatic ocular melanoma Cancer. ,vol. 52, pp. 334- 336 ,(1983) , 10.1002/1097-0142(19830715)52:2<334::AID-CNCR2820520225>3.0.CO;2-E
Takekazu Aoyama, Michael J. Mastrangelo, David Berd, Faith E. Nathan, Carol L. Shields, Jerry A. Shields, Ernest L. Rosato, Francis E. Rosato, Takami Sato, Protracted survival after resection of metastatic uveal melanoma. Cancer. ,vol. 89, pp. 1561- 1568 ,(2000) , 10.1002/1097-0142(20001001)89:7<1561::AID-CNCR21>3.0.CO;2-R
Michel Rivoire, Laurent Kodjikian, Stefano Baldo, Pierre Kaemmerlen, Sylvie Négrier, Jean-Dominique Grange, Treatment of liver metastases from uveal melanoma. Annals of Surgical Oncology. ,vol. 12, pp. 422- 428 ,(2005) , 10.1245/ASO.2005.06.032
Eddy C. Hsueh, Richard Essner, Leland J. Foshag, Xing Ye, He-Jing Wang, Donald L. Morton, Prolonged survival after complete resection of metastases from intraocular melanoma Cancer. ,vol. 100, pp. 122- 129 ,(2004) , 10.1002/CNCR.11872
R.J. Salmon, C. Levy, C. Plancher, T. Dorval, L. Desjardins, S. Leyvrazi, P. Pouillart, P. Schlienger, V Servois, B. Asselain, Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Ejso. ,vol. 24, pp. 127- 130 ,(1998) , 10.1016/S0748-7983(98)91485-8
Evangelos S. Gragoudas, Kathleen M. Egan, Johanna M. Seddon, Robert J. Glynn, Susan M. Walsh, Susan M. Finn, John E. Munzenrider, Myles D. Spar, Survival of Patents with Metastases from Uveal Melanoma Ophthalmology. ,vol. 98, pp. 383- 390 ,(1991) , 10.1016/S0161-6420(91)32285-1
Michael D. Onken, Lori A. Worley, Justis P. Ehlers, J. William Harbour, Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death Cancer Research. ,vol. 64, pp. 7205- 7209 ,(2004) , 10.1158/0008-5472.CAN-04-1750